GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 785 filers reported holding GLAXOSMITHKLINE PLC in Q1 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,388,000 | -93.6% | 123,697 | -94.5% | 0.01% | -94.0% |
| Q3 2020 | $84,777,000 | -25.3% | 2,252,302 | -19.0% | 0.20% | -29.2% |
| Q2 2020 | $113,426,000 | -11.7% | 2,780,733 | -18.0% | 0.28% | -25.7% |
| Q1 2020 | $128,472,000 | -30.2% | 3,390,656 | -13.4% | 0.38% | -7.8% |
| Q4 2019 | $183,940,000 | +10.6% | 3,914,442 | +0.5% | 0.41% | +0.2% |
| Q3 2019 | $166,310,000 | +5.7% | 3,896,668 | -0.9% | 0.41% | +7.1% |
| Q2 2019 | $157,399,000 | -4.4% | 3,933,001 | -0.1% | 0.38% | -6.1% |
| Q1 2019 | $164,569,000 | +7.1% | 3,938,000 | -2.1% | 0.41% | -2.9% |
| Q4 2018 | $153,689,000 | -4.8% | 4,022,220 | +0.1% | 0.42% | +11.1% |
| Q3 2018 | $161,487,000 | -8.2% | 4,020,095 | -7.9% | 0.38% | -26.9% |
| Q2 2018 | $176,000,000 | +5.0% | 4,366,175 | +1.7% | 0.52% | +6.0% |
| Q1 2018 | $167,696,000 | -6.1% | 4,292,194 | -14.7% | 0.49% | -3.4% |
| Q4 2017 | $178,515,000 | -19.7% | 5,032,859 | -8.1% | 0.50% | -21.0% |
| Q3 2017 | $222,289,000 | +14.3% | 5,475,086 | +21.4% | 0.64% | +13.9% |
| Q2 2017 | $194,521,000 | +25.5% | 4,511,155 | +22.7% | 0.56% | +26.7% |
| Q1 2017 | $155,050,000 | +7.6% | 3,677,654 | -1.7% | 0.44% | +2.3% |
| Q4 2016 | $144,102,000 | -40.5% | 3,741,920 | -33.3% | 0.43% | -37.9% |
| Q3 2016 | $242,017,000 | -11.0% | 5,611,334 | -10.6% | 0.70% | -12.2% |
| Q2 2016 | $271,882,000 | +19.1% | 6,273,227 | +11.5% | 0.79% | +12.0% |
| Q1 2016 | $228,222,000 | -8.3% | 5,628,165 | -8.7% | 0.71% | -10.0% |
| Q4 2015 | $248,770,000 | -7.1% | 6,165,301 | -11.5% | 0.79% | -9.2% |
| Q3 2015 | $267,817,000 | -8.4% | 6,965,310 | -0.7% | 0.87% | -1.0% |
| Q2 2015 | $292,244,000 | +10.9% | 7,016,676 | +22.9% | 0.88% | +9.1% |
| Q1 2015 | $263,521,000 | +14.5% | 5,710,088 | +6.0% | 0.80% | +12.9% |
| Q4 2014 | $230,167,000 | +1.5% | 5,385,273 | +9.2% | 0.71% | -2.6% |
| Q3 2014 | $226,671,000 | +0.1% | 4,930,866 | +16.4% | 0.73% | +2.7% |
| Q2 2014 | $226,511,000 | +26.0% | 4,235,435 | +25.8% | 0.71% | +18.3% |
| Q1 2014 | $179,832,000 | +5.9% | 3,365,739 | +5.8% | 0.60% | +2.2% |
| Q4 2013 | $169,796,000 | +9.5% | 3,180,290 | +2.9% | 0.59% | -1.5% |
| Q3 2013 | $154,995,000 | +2.3% | 3,089,410 | +1.9% | 0.60% | -0.5% |
| Q2 2013 | $151,516,000 | – | 3,032,138 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |